25.04
Lenz Therapeutics Inc Aktie (LENZ) Neueste Nachrichten
No Need For Reading Glasses? Vizz Eye Drop That Improves Near Vision Has FDA Nod - MSN
LENZ Therapeutics (LENZ) Receives a Buy from Citi - The Globe and Mail
Stock Analysis: Will LENZ Therapeutics Inc stock rally after Fed decisionsWeekly Investment Summary & Long-Term Safe Investment Ideas - BỘ NỘI VỤ
Saturn V Capital Management LP Invests $10.03 Million in LENZ Therapeutics, Inc. $LENZ - MarketBeat
Will LENZ Therapeutics Inc. stock gain from strong economyJuly 2025 Highlights & Smart Swing Trading Alerts - Newser
Transcript : LENZ Therapeutics, Inc. Presents at Citi Annual Global Healthcare Conference 2025, Dec-04-2025 10 - marketscreener.com
Lenz Therapeutics: A Close Look (NASDAQ:LENZ) - Seeking Alpha
LENZ Therapeutics (NASDAQ:LENZ) Shares Down 6.1%Here's What Happened - MarketBeat
Skandinaviska Enskilda Banken AB publ Acquires New Stake in LENZ Therapeutics, Inc. $LENZ - MarketBeat
Geode Capital Management LLC Grows Stock Position in LENZ Therapeutics, Inc. $LENZ - MarketBeat
Leadership: Lenz Therapeutics CEO gives people autonomy and responsibility - MSN
Lenz Therapeutics, Lotus Pharmaceutical Say New Drug Application for Presbyopia Treatment Submitted in South Korea - marketscreener.com
LENZ Therapeutics Announces MFDS Submission of New Drug Application for LNZ100 (VIZZ™) in South Korea for the Treatment of Presbyopia - The Manila Times
LENZ Therapeutics and Lotus Pharmaceutical Submit New Drug Application for VIZZ in South Korea to Treat Presbyopia - Quiver Quantitative
LENZ Therapeutics (Nasdaq: LENZ) logs 2nd ex-US VIZZ filing, up to $125 million milestones - Stock Titan
LENZ Therapeutics to Present at Upcoming Investor Conferences - The Manila Times
Piper Sandler 37th Annual Healthcare Conference - LENZ Therapeutics
LENZ Therapeutics (Nasdaq: LENZ) to webcast three December investor conferences - Stock Titan
LENZ Therapeutics (NASDAQ:LENZ) Insider Shawn Olsson Sells 10,000 Shares - MarketBeat
Building trade automation scripts for LENZ Therapeutics Inc.July 2025 Closing Moves & Verified Momentum Stock Ideas - newser.com
Ranking LENZ Therapeutics Inc. among high performing stocks via toolsEarnings Recap Summary & Short-Term High Return Strategies - newser.com
Olsson, Lenz therapeutics CCO, sells $261k in stock By Investing.com - Investing.com South Africa
How LENZ Therapeutics Inc. stock reacts to oil prices2025 Price Targets & High Return Stock Watch Alerts - newser.com
Olsson, Lenz therapeutics CCO, sells $261k in stock - Investing.com
LENZ Therapeutics CCO Shawn Olsson Sells 10,000 Shares - TradingView
Officer Olsson Sells 10,000 ($261K) Of LENZ Therapeutics Inc [LENZ] - TradingView
Is LENZ Therapeutics Inc. stock a buy in volatile marketsWeekly Profit Recap & Weekly Breakout Watchlists - newser.com
Signal strength of LENZ Therapeutics Inc. stock in tech scannersJuly 2025 Institutional & Weekly Stock Performance Updates - newser.com
How LENZ Therapeutics Inc. stock reacts to Fed rate cutsEarnings Risk Report & Technical Confirmation Alerts - newser.com
Is LENZ Therapeutics Inc. stock a dividend growth opportunityJuly 2025 Levels & Stepwise Entry and Exit Trade Signals - newser.com
Combining price and volume data for LENZ Therapeutics Inc.Trade Ideas & Stepwise Trade Signal Implementation - newser.com
Can LENZ Therapeutics Inc. stock maintain operating marginsRate Hike & Precise Swing Trade Entry Alerts - newser.com
Tools to assess LENZ Therapeutics Inc.’s risk profileWeekly Earnings Recap & Low Drawdown Trading Techniques - newser.com
Candriam S.C.A. Takes $5.02 Million Position in LENZ Therapeutics, Inc. $LENZ - MarketBeat
Chart overlay techniques for tracking LENZ Therapeutics Inc.Weekly Volume Report & Capital Protection Trading Alerts - newser.com
How interest rate cuts could boost LENZ Therapeutics Inc. stockWall Street Watch & Risk Adjusted Buy/Sell Alerts - newser.com
Calamos Advisors LLC Makes New $515,000 Investment in LENZ Therapeutics, Inc. $LENZ - MarketBeat
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):